Abstract

The integration of early palliative care in the management of metastatic upper gastrointestinal (GI) cancers has been proposed to improve patient outcomes by addressing symptom burden and enhancing quality of life. This study explores the relationship between early palliative care and survival rates in patients with metastatic upper GI cancers. Utilizing data from the EPIC (Early Palliative Care and Overall Survival in Patients with Metastatic Upper GI Cancers) trial, we analyze how the early introduction of palliative care impacts overall survival compared to standard care alone. The study cohort includes patients diagnosed with metastatic upper GI cancers who received early palliative care interventions alongside conventional oncological treatments. Key measures include overall survival rates, symptom control, and quality of life assessments. Results indicate that patients receiving early palliative care experience a statistically significant improvement in overall survival compared to those who receive standard care. Furthermore, early palliative care is associated with better symptom management, reduced hospitalizations, and improved patient-reported outcomes.